Medical Weight Management

Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist used in medical weight-management. Vydration offers provider-guided treatment options with appropriate consultation, screening, and individualized instructions.

How It Works

Provider-guided support built around your goals.

Tirzepatide works through GIP and GLP-1 receptor pathways involved in appetite, digestion, and metabolic regulation.

Eligibility, dosing, escalation, and follow-up should be determined by a licensed clinician based on your health history and response to treatment.

Compounded Tirzepatide is not FDA-approved and is not evaluated by the FDA for safety, effectiveness, or quality in the same way as FDA-approved medications.
Current Tirzepatide Options

Choose Your Package

Select an option to open the current product page, review available choices, and continue to purchase.

01

8-Week Starter Pack

Starter option for clients beginning a provider-guided Tirzepatide program.

Current price$800
View & Purchase →
02

Monthly Package

Monthly Tirzepatide package with available dose selection on the product page.

Current price$400
View & Purchase →
03

4 mL Single Vial

Single-vial Tirzepatide option for an eligible provider-guided treatment plan.

Current price$800
View & Purchase →
Before You Begin

What to expect.

Medical Screening

Eligibility is determined through health-history review and provider assessment.

Weekly Treatment

When prescribed, Tirzepatide is generally used on a weekly schedule according to your clinician's instructions.

Ongoing Follow-Up

Your provider may adjust your treatment plan based on response, tolerance, and individual goals.

Questions before you start?

Book a consultation with the Vydration team to review eligibility and Tirzepatide options.

Prescription treatment requires medical evaluation and eligibility. Individual results vary. Pricing and product availability may change.